Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $9.09, but opened at $9.43. Bavarian Nordic shares last traded at $9.43, with a volume of 112 shares changing hands.
Bavarian Nordic Price Performance
The stock has a market cap of $2.24 billion, a P/E ratio of 10.84 and a beta of 1.23. The stock’s 50-day moving average is $11.79 and its two-hundred day moving average is $10.65.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last released its quarterly earnings data on Friday, November 14th. The company reported $0.72 EPS for the quarter. Bavarian Nordic had a net margin of 21.95% and a return on equity of 12.35%. The business had revenue of $281.11 million during the quarter. On average, analysts anticipate that Bavarian Nordic will post 0.67 EPS for the current fiscal year.
About Bavarian Nordic
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Read More
- Five stocks we like better than Bavarian Nordic
- What to Know About Investing in Penny Stocks
- Why These 3 Tech Stocks Could Be the Best Opportunities You’re Overlooking
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Does Insider Buying Signal Value in the WD-40 Company?
- About the Markup Calculator
- 5 Small-Cap Stocks With Impressive Growth and Upside Potential
Receive News & Ratings for Bavarian Nordic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic and related companies with MarketBeat.com's FREE daily email newsletter.
